Close

Lilly's (LLY) Newest Lung Cancer Drug May Have $1.5B/yr Potential

August 13, 2013 9:13 AM EDT Send to a Friend
On Tuesday shares of Eli Lilly (NYSE: LLY) moved higher after it announced that SQUIRE, a recently completed Phase III ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login